Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Case report

Scar site metastasis of renal cell carcinoma diagnosed on-site cytology: a case report

Authors: Santosh Tummidi, Pragati Sathe, Prachi Gholap, Manoj Patil, Kanchan Kothari

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

Renal cell carcinomas (RCCs) have a propensity for widespread metastases and a wide range of survival rates. They can spread into adjacent organs by direct extension and can invade local or distant sites by lymphatic, hematogenous or lympho-hematogeneous pathways. Scar site metastasis is very rare.

Case presentation

We report a rare case of scar site RCC metastasis in a patient who underwent left radical nephrectomy 10 months ago.

Conclusion

FNAC is a simple and easy technique that can help in the definitive diagnosis of subcutaneous lesions. A correct early stage diagnosis of metastatic RCC can considerably improve the survival rates.
Literature
1.
Suresh K, Pramod KS, Malay KB. Isolated abdominal wall metastasis from renal cell carcinoma: unusual presentation. Adv Biomed Res. 2015;4:65.CrossRef
2.
Tunio MA, Hashmi A, Epistaxis RM. Proptosis- unusual primary manifestations of metastatic renal cell carcinoma. Pak J Med Sci. 2009;25:1012–4.
3.
Tunio MA, Hashmi A, Rafi M. Renal cell carcinoma presenting as skin and ipsilateral testicular metastasis. Isra Med J. 2009;1:79–81.
4.
Syriac S, Boergert S, Ganesan SI. FNA diagnosis of cutaneous metastasis of renal cell carcinoma with initial presentation as scalp lesion. Ann Clin Cytol Pathol. 2016;2(1):10–5.
5.
Mutahir AT, Altaf H, Muhammad M, Rehan M. Isolated scar-site metastasis after radical nephrectomy for localized renal cell carcinoma. Pak J Surg. 2011;27(3):229–31.
6.
Perna AG, Ostler DA, Ivan D, Lazar AJ, Diwan AH, Prieto VG, et al. Renal cell carcinoma marker (RCC-ma) is specific for cutaneous metastasis of renal cell carcinoma. J Cutan Pathol. 2007;34:381–5.CrossRefPubMed
7.
Reymond MA, Schneider C, Kastl S, Hohenberger W, Kockerling F. The pathogenesis of port site recurrences. J Gastrointest Surg. 1998;2:406–14.CrossRefPubMed
8.
Fornara P, Zacharias M, Wagner S. Port-site metastases: fact or fiction? Urol Int. 2003;71:136–42.CrossRefPubMed
9.
Ji-Jian C, Kamran A, Zahoor F, Sheikh M. Solitary renal fossa recurrence of renal cell carcinoma after nephrectomy. Rev Urol. 2014;16(2):76–82.
Metadata
Title
Scar site metastasis of renal cell carcinoma diagnosed on-site cytology: a case report
Authors
Santosh Tummidi
Pragati Sathe
Prachi Gholap
Manoj Patil
Kanchan Kothari
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4167-2

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue

Research article

Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies

Research article

M1 macrophage recruitment correlates with worse outcome in SHH Medulloblastomas

Case report

Combining genomic analyses with tumour-derived slice cultures for the characterization of an EGFR-activating kinase mutation in a case of glioblastoma

Research article

Increased systemic zonula occludens 1 associated with inflammation and independent biomarker in patients with hepatocellular carcinoma

Research article

The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological staging

Research article

MEF2 plays a significant role in the tumor inhibitory mechanism of encapsulated RENCA cells via EGF receptor signaling in target tumor cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits